Skip main navigation

Official websites use .mil
A .mil website belongs to an official U.S. Department of Defense organization.

Secure .mil websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.

Skip to main content

Military Health System

TRICARE Policy Manual 6010.63-M, April 2021
Other Services
Chapter 8
Section 17.1
Lymphedema
Issue Date:  September 12, 1986
Revision:  C-47, March 13, 2026
1.0  HCPCS CODES
Level II Codes E0650 - E0673
2.0  DESCRIPTION
Lymphedema refers to edema from accumulation of lymph secondary to obstruction to its flow.
3.0  POLICY
3.1  Lymphovenous anastomosis by open surgical correction is a covered benefit.
3.2  Lymphedema pumps, both segmental and non-segmental, are authorized durable medical equipment for both institutional and home use.
4.0  POLICY CONSIDERATIONS
4.1  A physician’s prescription is required for all claims for the segmental type pumps with or without a calibrated pressure gradient.
4.2  When purchased or rented as durable medical equipment, prior authorization is required for coverage of pneumatic compression devices, including intermittent pneumatic compression pumps and sequential pneumatic compression devices, to demonstrate that the requested pump is medically necessary and appropriate for the patient’s specific medical needs, as determined by the ordering physician based on the individual patient’s specific condition and severity, risk factors, and keeping in practice with published national clinical practice guidelines and recommendations from the American Venous Forum (AVF), American Vein and Lymphatic Society (AVLS), and the Society for Vascular Medicine (SVM). This determination shall be confirmed by the contractor as part of their prior authorization review prior to coverage, including documentation of the specific patient indications for intermittent pneumatic compression or sequential pneumatic compression. Generic prescriptions or requests for authorization without evidence of this evaluation should be returned for additional documentation, to include length of anticipated need. Initial authorization shall not exceed 180 days, and continued coverage may be approved upon adequate documentation from the prescribing physician.
5.0  EXCEPTIOnExclusions
5.1  Lymphovenous anastomosis by use of a special needle for insertion of lymphatic vessels directly into the veins is not a covered benefit.
5.2  Non-pneumatic compression devices (e.g., Koya Dayspring) are unproven for the treatment of lymphedema.
- END -
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery